Personalized Diagnosis and Therapy for Multiple Sclerosis
We all agree that people with MS need to be cared in a profoundly personalized way. The care of the patient with MS is still based on the presence of relapses, so their successful diagnosis and treatment is fundamental and will condition the therapeutic strategies to follow with the patient. The tre...
Збережено в:
| Формат: | Online |
|---|---|
| Мова: | Англійська |
| Опубліковано: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Предмети: | |
| Онлайн доступ: | ONIX_20221025_9783036552552_72 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| _version_ | 1869526881874739200 |
|---|---|
| collection | Directory of Open Access Books |
| description | We all agree that people with MS need to be cared in a profoundly personalized way. The care of the patient with MS is still based on the presence of relapses, so their successful diagnosis and treatment is fundamental and will condition the therapeutic strategies to follow with the patient. The treatment strategies are a highly controversial topic of debate that is increasingly supported by robust objective biological markers of response and that also increasingly take into account the dynamics and predictors of cognitive impairment along the disease course, which includes the adoption of new trends in the field of machine learning techniques. However, we all know that patient care goes beyond being treated with drugs and we cannot overlook reminding patients of the importance of their lifestyle behaviors that vary according to the MS phenotype, in order to improve their quality of life. Teleconsultation is a new care strategy proved to be feasible and well-received by patients with MS that will undoubtedly become reinforced because it will allow a closer follow-up of the patient without the need for displacement. |
| format | Online |
| id | doab-20.500.12854ir-93218 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-932182024-03-31T13:09:07Z Personalized Diagnosis and Therapy for Multiple Sclerosis Ramo-Tello, Cristina M. cognition cognitive impairment neuroimaging longitudinal predictors multiple sclerosis lifestyle behavior MS management MS phenotype quality of life natalizumab extended interval dose biomarker CD49d sVCAM-1 immunomonitoring personalized dose prognosis machine learning artificial intelligence relapse pseudo-relapses methylprednisolone treatment algorithm multiple sclerosis treatment escalating strategy he-DMT diseases modifying therapies early intense therapy teleconsultation internet feasibility digital health neuromyelitis optica spectrum disorder health-related quality of life mood n/a thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine We all agree that people with MS need to be cared in a profoundly personalized way. The care of the patient with MS is still based on the presence of relapses, so their successful diagnosis and treatment is fundamental and will condition the therapeutic strategies to follow with the patient. The treatment strategies are a highly controversial topic of debate that is increasingly supported by robust objective biological markers of response and that also increasingly take into account the dynamics and predictors of cognitive impairment along the disease course, which includes the adoption of new trends in the field of machine learning techniques. However, we all know that patient care goes beyond being treated with drugs and we cannot overlook reminding patients of the importance of their lifestyle behaviors that vary according to the MS phenotype, in order to improve their quality of life. Teleconsultation is a new care strategy proved to be feasible and well-received by patients with MS that will undoubtedly become reinforced because it will allow a closer follow-up of the patient without the need for displacement. 2022-10-25T09:02:37Z 2022-10-25T09:02:37Z 2022 book ONIX_20221025_9783036552552_72 9783036552552 9783036552569 https://directory.doabooks.org/handle/20.500.12854/93218 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/6116 https://mdpi.com/books/pdfview/book/6116 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-5256-9 10.3390/books978-3-0365-5256-9 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036552552 9783036552569 124 open access |
| spellingShingle | cognition cognitive impairment neuroimaging longitudinal predictors multiple sclerosis lifestyle behavior MS management MS phenotype quality of life natalizumab extended interval dose biomarker CD49d sVCAM-1 immunomonitoring personalized dose prognosis machine learning artificial intelligence relapse pseudo-relapses methylprednisolone treatment algorithm multiple sclerosis treatment escalating strategy he-DMT diseases modifying therapies early intense therapy teleconsultation internet feasibility digital health neuromyelitis optica spectrum disorder health-related quality of life mood n/a thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine Personalized Diagnosis and Therapy for Multiple Sclerosis |
| title | Personalized Diagnosis and Therapy for Multiple Sclerosis |
| title_full | Personalized Diagnosis and Therapy for Multiple Sclerosis |
| title_fullStr | Personalized Diagnosis and Therapy for Multiple Sclerosis |
| title_full_unstemmed | Personalized Diagnosis and Therapy for Multiple Sclerosis |
| title_short | Personalized Diagnosis and Therapy for Multiple Sclerosis |
| title_sort | personalized diagnosis and therapy for multiple sclerosis |
| topic | cognition cognitive impairment neuroimaging longitudinal predictors multiple sclerosis lifestyle behavior MS management MS phenotype quality of life natalizumab extended interval dose biomarker CD49d sVCAM-1 immunomonitoring personalized dose prognosis machine learning artificial intelligence relapse pseudo-relapses methylprednisolone treatment algorithm multiple sclerosis treatment escalating strategy he-DMT diseases modifying therapies early intense therapy teleconsultation internet feasibility digital health neuromyelitis optica spectrum disorder health-related quality of life mood n/a thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine |
| topic_facet | cognition cognitive impairment neuroimaging longitudinal predictors multiple sclerosis lifestyle behavior MS management MS phenotype quality of life natalizumab extended interval dose biomarker CD49d sVCAM-1 immunomonitoring personalized dose prognosis machine learning artificial intelligence relapse pseudo-relapses methylprednisolone treatment algorithm multiple sclerosis treatment escalating strategy he-DMT diseases modifying therapies early intense therapy teleconsultation internet feasibility digital health neuromyelitis optica spectrum disorder health-related quality of life mood n/a thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine |
| url | ONIX_20221025_9783036552552_72 |